Abiopharma

News list

WILSON TROY EDWARD 🟢 acquired 50.0K shares of Kura Oncology, Inc. (KURA) at $8.20 Transaction Date: Sep 08, 2025 | Filing ID: 023974

Full text

News bot Sept. 9, 2025, 8:30 p.m.
🔍 WILSON TROY EDWARD (Executive)

Company: Kura Oncology, Inc. (KURA)

Report Date: 2025-09-08
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 2
- Total shares acquired: 50,000
- Total shares held: 579,194
Detailed Transactions and Holdings:
- Acquired 50,000 shares of Common Stock at $8.2029 per share (Direct)
  Date: 2025-09-08 | Code: P | equity_swap_involved: 0 | shares_owned_after: 100,968.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-08 | Code: H | nature_of_ownership: by One Fish Two Fish Revocable Trust | shares_owned_after: 279,194.00
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-08 | Code: H | nature_of_ownership: by Lorax Charitable Remainder Unitrust | shares_owned_after: 300,000.00
Footnotes:
- F1: This transaction was executed in multiple trades at prices ranging from $8.135 to $8.24. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakesto provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.